Steroid induction regimen for juvenile idiopathic arthritis
Not Applicable
Completed
- Conditions
- Juvenile idiopathic arthritisMusculoskeletal DiseasesJuvenile arthritis
- Registration Number
- ISRCTN16649996
- Lead Sponsor
- Alder Hey Children’s Foundation NHS Trust (UK)
- Brief Summary
2020 results in https://pubmed.ncbi.nlm.nih.gov/32758350/(added 10/08/2020)
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 297
Inclusion Criteria
Patients with JIA and their parents/carers will be eligible to take part in the qualitative research aspect of the trial
Exclusion Criteria
Patients aged under 8 years and patients/carers residing more that one days' travel away from the primary research site (Liverpool)
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Develop outcomes of the feasibility study including a report to HTA with assessment of the proposed intervention and control arms for definitive study
- Secondary Outcome Measures
Name Time Method <br> 1. A comprehensive assessment of current UK practice as regards JIA CS treatment, and potential trial capability and acceptability (by conducting a national survey)<br> 2. Ascertainment of HCP views on the most appropriate patient group(s) and control and intervention arms (through a stakeholder consensus meeting)<br> 3. A qualitative study of parent and patient perspectives in relation to a future RCT of CS<br> 4. The choice of a primary outcome measure for a clinical trial in children and young people with JIA (through literature review, Delphi process and stakeholder consensus meeting)<br> 5. Undertake a prospective feasibility study for the early induction of remission in children and young people with JIA testing chosen primary outcome, treatment arms and JIA subgroups to be studied<br>